Italy · AIFA medicine catalogue

EMTRICITABINA/RILPIVIRINA/TENOFOVIR ALAFENAMIDE VIATRIS

A source-listed package record. Different packs may share the same medicine name.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
052459031
Form
Compressa rivestita con film
Composition / generic term
EMTRICITABINA/RILPIVIRINA/TENOFOVIR ALAFENAMIDE
Company as listed by source
VIATRIS LIMITED
Source status
Autorizzata
Supply classification
Medicinali soggetti a prescrizione medica limitativa, da rinnovare volta per volta, vendibili al pubblico su prescrizione di centri ospedalieri o di specialisti

Source-listed ingredients

  • EMTRICITABINA — 200 milligrammi
  • RILPIVIRINA — 25 milligrammi
  • TENOFOVIR ALAFENAMIDE — 25 milligrammi

These values do not establish equivalence or a dose recommendation.

Packages

  • 200 mg / 25 mg / 25 mg - Compressa rivestita con film - Uso orale - Blister (OPA/alu/PE/essiccante/HDPE-alu/PE) - 30 x 1 compresse (dose unitaria)

Source and coverage

Open AIFA medicine catalogue →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse Italy records →
EMTRICITABINA/RILPIVIRINA/TENOFOVIR ALAFENAMIDE VIATRIS — Italy | Molindra Medicines